Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.2M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
71.2K
-
Shares change
-
-121K
-
Total reported value, excl. options
-
$135K
-
Value change
-
-$363K
-
Number of buys
-
7
-
Number of sells
-
-17
-
Price
-
$1.90
Significant Holders of Alaunos Therapeutics, Inc. - Common Stock (TCRT) as of Q4 2024
33 filings reported holding TCRT - Alaunos Therapeutics, Inc. - Common Stock as of Q4 2024.
Alaunos Therapeutics, Inc. - Common Stock (TCRT) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.2K shares
of 2.2M outstanding shares and own 3.23% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (21.4K shares), VANGUARD GROUP INC (21K shares), GEODE CAPITAL MANAGEMENT, LLC (15.2K shares), UBS Group AG (7.87K shares), CITIGROUP INC (1.6K shares), Tower Research Capital LLC (TRC) (1.15K shares), MORGAN STANLEY (1.05K shares), OSAIC HOLDINGS, INC. (860 shares), BNP PARIBAS FINANCIAL MARKETS (343 shares), and CIBC Private Wealth Group LLC (300 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.